DH ENCHANTMENT, INC., a company primarily engaged in the sale and distribution of COVID-19 rapid antigen tester sets through its Hong Kong subsidiary, Ho Shun Yi Limited, has released its Form 10-Q report for the three months ended December 31, 2023. The report highlights significant financial and operational challenges faced by the company during this period.
Financial Highlights
- Revenue, net: $0 million for the three months ended December 31, 2023, compared to $7.325 million for the same period in 2022, indicating a significant decrease in sales activity.
- Loss from Operations: $(8,723) for the three months ended December 31, 2023, compared to $(50,553) for the same period in 2022, reflecting a reduction in operating losses.
- Net Loss: $(11,449) for the three months ended December 31, 2023, compared to $(57,033) for the same period in 2022, showing an improvement in net loss.
- Net loss per share – Basic and Diluted: $(0.00) for both the three and nine months ended December 31, 2023 and 2022, indicating no change in per-share loss.
Business Highlights
- Revenue Segments: The company generates revenue primarily from the sale and distribution of COVID-19 rapid antigen tester sets through its Hong Kong subsidiary, Ho Shun Yi Limited. The revenue for the nine months ended December 31, 2023, was significantly lower compared to the same period in 2022, indicating a decline in demand or market saturation.
- Geographical Performance: All of the company's customers are located in Hong Kong, which means the company's operations and revenue are heavily dependent on the Hong Kong market. This concentration poses a risk if there are adverse economic or political changes in the region.
- Sales Units: For the nine months ended December 31, 2023, certain inventory items were sold at cost and below cost due to close expiration dates, which impacted the gross profit negatively.
- Future Outlook: The company is facing going concern uncertainties due to its inability to establish a consistent revenue stream sufficient to cover operating costs. Management is relying on financial support from stockholders to continue operations, but there is no assurance of securing sufficient funds.
- Operational Challenges: The company has not engaged any consultants for expanding sales channels or developing marketing strategies during the nine months ended December 31, 2023, which may have contributed to the decline in sales and marketing expenses.
- Regulatory Environment: The company operates in a complex regulatory environment in Hong Kong and is subject to potential risks from changes in PRC regulations that could impact its ability to transfer cash or assets between subsidiaries and the holding company.
SEC Filing: